GE HealthCare Technologies Inc. (GEHC) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally.
Total Assets Chart for GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. (GEHC) total assets for FY2025 were USD 36.9B, a 11.5% change from FY2024. GE HealthCare Technologies Inc.'s total assets grew from USD 24.2B in 2020 to USD 36.9B in 2025 (52.3% over 5 years). Total assets compound annual growth rate: 5-year CAGR of 8.8%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $31.98B
- Implied Share Price
- $70.31
- Enterprise Value
- $39.19B
- Revenue (TTM)
- $21.27B
- EBITDA
- $3.59B
- Profit Margin
- 9.33%
- Trailing P/E
- 16.16
- Forward P/E
- 13.83
- Price/Book (MRQ)
- 2.80
- Price/Sales (TTM)
- 1.50
- EV/EBITDA
- 10.61
- EV/Revenue
- 1.84
- Dividend Yield
- 0.20%
- Book Value
- $24.30
- Free Cash Flow (FY2025)
- $1.51B
- Free Cash Flow Yield
- 4.71%
Snapshot as of 6th August 2026 — not point-in-time controlled, may lag the live market by a few days.